{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:28:47Z","timestamp":1764959327803,"version":"3.46.0"},"reference-count":28,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T00:00:00Z","timestamp":1764892800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Kanazawa University Hospital and Initiative for Realizing Diversity in the Research Environment, MEXT"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS One"],"abstract":"<jats:p>\n                    d-serine administration prevents kidney damage in murine models of acute kidney injury, and risperidone inhibits the activity of d-amino acid oxidase, which regulate plasma d-amino acid levels. This pilot randomized controlled trial investigated the effects of risperidone on glucose, amino acid metabolism, and kidney function in healthy adults. Healthy adults with a homeostasis model assessment of insulin resistance (HOMA-IR) of \u2265 1.6 and estimated glomerular filtration rate (eGFR) of \u2265 60\u2009mL\/min\/1.73m\n                    <jats:sup>2<\/jats:sup>\n                    were randomly assigned to the risperidone and control groups. The risperidone group received 0.5\u2009mg\/day risperidone for 4 days. The primary outcome was mean change in HOMA-IR on day 5, and the secondary outcomes were changes in d-amino acid levels, eGFR, and urinary albumin. Seven participants were randomized to the risperidone and control groups. The changes in HOMA-IR, eGFR, and urinary albumin on day 5 were not significantly different between the two groups (all p\u2009&gt;\u20090.05). Mean changes in plasma d-serine level and urinary d-serine\/creatinine ratio were significantly higher in the risperidone group than in the control group (0.2 vs. \u22120.3 nmol\/mL, p\u2009=\u20090.03 and 38.2 vs. \u221225.8 nmol\/mL, p\u2009=\u20090.01, respectively). Short-term risperidone affects d-serine metabolism without instigating acute adverse effects on kidney or glucose homeostasis in healthy individuals.\n                  <\/jats:p>\n                  <jats:p>\n                    <jats:bold>Clinical Trial Registry number:<\/jats:bold>\n                    This study was registered with the Japan Registry for Clinical Trials (jRCTs041210165).\n                  <\/jats:p>","DOI":"10.1371\/journal.pone.0324222","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:24:37Z","timestamp":1764959077000},"page":"e0324222","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of risperidone on amino acid metabolism, glucose, and kidney function in healthy adults: A pilot randomized controlled trial"],"prefix":"10.1371","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4108-5229","authenticated-orcid":true,"given":"Megumi","family":"Oshima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Toyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Nakade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sakae","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisayuki","family":"Ogura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiori","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Yuasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Koshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taichiro","family":"Minami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Sako","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Tsuge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryo","family":"Nishioka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taro","family":"Miyagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyoaki","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinji","family":"Kitajima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ichiro","family":"Mizushima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akinori","family":"Hara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihiko","family":"Sakai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miho","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Tokumaru","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Makoto","family":"Tsubomoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mitsuru","family":"Kikuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9419-6101","authenticated-orcid":true,"given":"Mitsutoshi","family":"Nakada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Mita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4756-5207","authenticated-orcid":true,"given":"Yasunori","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2025,12,5]]},"reference":[{"key":"pone.0324222.ref001","article-title":"2023 USRDS Annual Data Report: Epidemiology of kidney disease in the United States (Report No)","author":"United States Renal Data System","year":"2023"},{"issue":"5","key":"pone.0324222.ref002","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/j.ajkd.2015.10.011","article-title":"Renin-Angiotensin System Inhibitors and Kidney and Cardiovascular Outcomes in Patients With CKD: A Bayesian Network Meta-analysis of Randomized Clinical Trials","volume":"67","author":"X Xie","year":"2016","journal-title":"Am J Kidney Dis"},{"issue":"10365","key":"pone.0324222.ref003","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Nuffield Department of Population Health Renal Studies Group, SGLT2 inhibitor Meta-Analysis Cardio-Renal Trialists\u2019 Consortium","year":"2022","journal-title":"Lancet"},{"issue":"20","key":"pone.0324222.ref004","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97957","article-title":"Gut microbiota-derived D-serine protects against acute kidney injury","volume":"3","author":"Y Nakade","year":"2018","journal-title":"JCI Insight"},{"issue":"6","key":"pone.0324222.ref005","doi-asserted-by":"crossref","DOI":"10.1152\/ajprenal.00198.2021","article-title":"Protective effect of d-alanine against acute kidney injury","volume":"322","author":"Y Iwata","year":"2022","journal-title":"Am J Physiol Renal Physiol"},{"issue":"10","key":"pone.0324222.ref006","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.34067\/KID.0000832021","article-title":"d-Serine Mediates Cellular Proliferation for Kidney Remodeling","volume":"2","author":"A Hesaka","year":"2021","journal-title":"Kidney360"},{"issue":"1","key":"pone.0324222.ref007","doi-asserted-by":"crossref","first-page":"21773","DOI":"10.1038\/s41598-022-26175-1","article-title":"Increased levels of oral Streptococcus-derived D-alanine in patients with chronic kidney disease and diabetes mellitus","volume":"12","author":"Y Nakade","year":"2022","journal-title":"Sci Rep"},{"key":"pone.0324222.ref008","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.chroma.2018.07.076","article-title":"Development of an online two-dimensional high-performance liquid chromatographic system in combination with tandem mass spectrometric detection for enantiomeric analysis of free amino acids in human physiological fluid","volume":"1570","author":"C Ishii","year":"2018","journal-title":"J Chromatogr A"},{"issue":"11","key":"pone.0324222.ref009","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.34067\/KID.0004282021","article-title":"Identification of Diabetic Nephropathy in Patients Undergoing Kidney Biopsy through Blood and Urinary Profiles of d-Serine","volume":"2","author":"Y Iwata","year":"2021","journal-title":"Kidney360"},{"key":"pone.0324222.ref010","first-page":"4","article-title":"Antipsychotics in the treatment of schizophrenia: an overview","author":"R Tandon","year":"2011","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"pone.0324222.ref011","doi-asserted-by":"crossref","first-page":"149","DOI":"10.5582\/bst.2014.01034","article-title":"Evaluation of human D-amino acid oxidase inhibition by anti-psychotic drugs in vitro","volume":"8","author":"M Shishikura","year":"2014","journal-title":"Biosci Trends"},{"key":"pone.0324222.ref012","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.lfs.2016.06.021","article-title":"Effect of risperidone on plasma d-serine concentration in rats post-administered with d-serine","volume":"158","author":"M Onozato","year":"2016","journal-title":"Life Sci"},{"issue":"7","key":"pone.0324222.ref013","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1177\/0269881109102644","article-title":"The effect of risperidone on D-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of schizophrenia","volume":"24","author":"RM Abou El-Magd","year":"2010","journal-title":"J Psychopharmacol"},{"issue":"9","key":"pone.0324222.ref014","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/j.clinthera.2023.07.002","article-title":"Association Between Risperidone Use and Kidney Function Decline in Patients with Schizophrenia: A Retrospective Cohort Study","volume":"45","author":"M Oshima","year":"2023","journal-title":"Clin Ther"},{"issue":"4","key":"pone.0324222.ref015","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s40263-017-0421-4","article-title":"A Retrospective Cohort Study of Acute Kidney Injury Risk Associated with Antipsychotics","volume":"31","author":"Y Jiang","year":"2017","journal-title":"CNS Drugs"},{"issue":"8","key":"pone.0324222.ref016","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00228-022-03339-6","article-title":"Incidence of hospital contacts with acute kidney injury after initiation of second-generation antipsychotics in older adults: a Danish population-based cohort study","volume":"78","author":"R Sharon","year":"2022","journal-title":"Eur J Clin Pharmacol"},{"issue":"4","key":"pone.0324222.ref017","doi-asserted-by":"crossref","first-page":"242","DOI":"10.7326\/M13-2796","article-title":"Atypical antipsychotic drugs and the risk for acute kidney injury and other adverse outcomes in older adults: a population-based cohort study","volume":"161","author":"YJ Hwang","year":"2014","journal-title":"Ann Intern Med"},{"issue":"6","key":"pone.0324222.ref018","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"S Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"key":"pone.0324222.ref019","doi-asserted-by":"crossref","first-page":"104635","DOI":"10.1016\/j.ebiom.2023.104635","article-title":"Combining robust urine biomarkers to assess chronic kidney disease progression","volume":"93","author":"F Bienaim\u00e9","year":"2023","journal-title":"EBioMedicine"},{"issue":"1","key":"pone.0324222.ref020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246211","article-title":"A comparison of the metabolic side-effects of the second-generation antipsychotic drugs risperidone and paliperidone in animal models","volume":"16","author":"HN Boyda","year":"2021","journal-title":"PLoS One"},{"issue":"6","key":"pone.0324222.ref021","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1592\/phco.23.6.735.32178","article-title":"Risperidone-associated diabetes mellitus: a pharmacovigilance study","volume":"23","author":"EA Koller","year":"2003","journal-title":"Pharmacotherapy"},{"issue":"10","key":"pone.0324222.ref022","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1080\/17460441.2018.1524459","article-title":"Drug discovery strategies and the preclinical development of D-amino-acid oxidase inhibitors as antipsychotic therapies","volume":"13","author":"B Szil\u00e1gyi","year":"2018","journal-title":"Expert Opin Drug Discov"},{"issue":"1","key":"pone.0324222.ref023","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jbiosc.2010.08.019","article-title":"Alterations in D-amino acid concentrations and microbial community structures during the fermentation of red and white wines","volume":"111","author":"S Kato","year":"2011","journal-title":"J Biosci Bioeng"},{"key":"pone.0324222.ref024","doi-asserted-by":"crossref","first-page":"46289","DOI":"10.1038\/srep46289","article-title":"Characterization of chiral amino acids from different milk origins using ultra-performance liquid chromatography coupled to ion-mobility mass spectrometry","volume":"7","author":"H Tian","year":"2017","journal-title":"Sci Rep"},{"issue":"3","key":"pone.0324222.ref025","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1007\/s00726-022-03140-w","article-title":"Chiral resolution of plasma amino acids reveals enantiomer-selective associations with organ functions","volume":"54","author":"M Suzuki","year":"2022","journal-title":"Amino Acids"},{"issue":"10","key":"pone.0324222.ref026","doi-asserted-by":"crossref","first-page":"16125","DOI":"10.1038\/nmicrobiol.2016.125","article-title":"Interplay between microbial d-amino acids and host d-amino acid oxidase modifies murine mucosal defence and gut microbiota","volume":"1","author":"J Sasabe","year":"2016","journal-title":"Nat Microbiol"},{"issue":"5","key":"pone.0324222.ref027","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/JCP.0b013e318297980e","article-title":"Weight gain in risperidone therapy: investigation of peripheral hypothalamic neurohormone levels in psychotic patients","volume":"33","author":"T Yanik","year":"2013","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"pone.0324222.ref028","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41386-021-01163-7","article-title":"Metabolic adverse effects of off-label use of second-generation antipsychotics in the adult population: a systematic review and meta-analysis","volume":"47","author":"N Stogios","year":"2022","journal-title":"Neuropsychopharmacology"}],"container-title":["PLOS One"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324222","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T18:24:42Z","timestamp":1764959082000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0324222"}},"subtitle":[],"editor":[{"given":"Kuo-Cherh","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2025,12,5]]},"references-count":28,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2025,12,5]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0324222","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,5]]}}}